Search Results - "Mercer, D.F"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Characterization of the Ileal Microbiota in Rejecting and Nonrejecting Recipients of Small Bowel Transplants by Oh, P. L., Martínez, I., Sun, Y., Walter, J., Peterson, D.A., Mercer, D. F.

    Published in American journal of transplantation (01-03-2012)
    “…Small bowel transplantation can be a life‐preserving procedure for patients with irreversible intestinal failure. Allograft rejection remains a major source of…”
    Get full text
    Journal Article
  2. 2

    Impact of Immunoglobulin Therapy in Intestinal Transplant Recipients With Posttransplantation Hypogammaglobulinemia by Poole, J.A, Qiu, F, Kalil, A.C, Grant, W, Mercer, D.F, Florescu, D.F

    Published in Transplantation proceedings (01-03-2016)
    “…Abstract Background Severe hypogammaglobulinemia (HGG) (IgG <400 mg/dL) following intestinal transplantation is common. Although IgG replacement therapy is…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Elevated ST2 Distinguishes Incidences of Pediatric Heart and Small Bowel Transplant Rejection by Mathews, L. R., Lott, J. M., Isse, K., Lesniak, A., Landsittel, D., Demetris, A. J., Sun, Y., Mercer, D. F., Webber, S. A., Zeevi, A., Fischer, R. T., Feingold, B., Turnquist, H. R.

    Published in American journal of transplantation (01-03-2016)
    “…Elevated serum soluble (s) suppressor of tumorigenicity‐2 is observed during cardiovascular and inflammatory bowel diseases. To ascertain whether modulated ST2…”
    Get full text
    Journal Article
  5. 5

    Risk factors for Clostridium difficile infection in intestinal transplant recipients during the first year post‐transplant by Guzman, L., Qiu, F., Kalil, A.C., Mercer, D.F., Langnas, A., Florescu, D.F.

    Published in Transplant infectious disease (01-04-2018)
    “…Background Clostridium difficile is the most common cause of healthcare‐associated infectious diarrhea. Risk factors for C. difficile infections (CDI) in…”
    Get full text
    Journal Article
  6. 6

    Parvovirus Associated Fulminant Hepatic Failure and Aplastic Anemia Treated Successfully With Liver and Bone Marrow Transplantation. A Report of Two Cases by Bathla, L., Grant, W. J., Mercer, D. F., Vargas, L. M., Gebhart, C. L., Langnas, A. N.

    Published in American journal of transplantation (01-11-2014)
    “…Aplastic anemia (AA) has been observed in nearly a third of patients undergoing liver transplantation (LT) for non‐A‐E fulminant hepatic failure (FHF). Few of…”
    Get full text
    Journal Article
  7. 7

    Staphylococcus aureus infections after liver transplantation by Florescu, D. F., McCartney, A. M., Qiu, F., Langnas, A. N., Botha, J., Mercer, D. F., Grant, W., Kalil, A. C.

    Published in Infection (01-06-2012)
    “…Background More data on the risk factors and outcomes after Staphylococcus aureus infections in liver transplantation are needed. Methods Liver recipients with…”
    Get full text
    Journal Article
  8. 8

    Incidence and outcome of fungal infections in pediatric small bowel transplant recipients by Florescu, D.F., Islam, K.M., Grant, W., Mercer, D.F., Langnas, A., Botha, J., Nielsen, B., Kalil, A.C.

    Published in Transplant infectious disease (01-12-2010)
    “…D.F. Florescu, K.M. Islam, W. Grant, D.F. Mercer, A. Langnas, J. Botha, B. Nielsen, A.C. Kalil. Incidence and outcome of fungal infections in pediatric small…”
    Get full text
    Journal Article
  9. 9